Company
Tusk Therapeutics
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Tusk Therapeutics (Stevenage, UK – acquired by Roche) is developing novel immune modulating antibodies based on an in-depth understanding of the innate and adaptive immune system.
Loading relationship preview